Total Payments
$9,471
2024 Payments
$616.33
Companies
40
Transactions
265
Medicare Patients
3,898
Medicare Billing
$399,845
Payment Breakdown by Category
Food & Beverage$7,718 (81.5%)
Travel$1,674 (17.7%)
Education$78.98 (0.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,718 | 259 | 81.5% |
| Travel and Lodging | $1,674 | 4 | 17.7% |
| Education | $78.98 | 2 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Philips Electronics North America Corporation | $1,369 | 2 | $0 (2020) |
| Medtronic, Inc. | $1,368 | 18 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $980.22 | 30 | $0 (2023) |
| Amgen Inc. | $846.84 | 32 | $0 (2024) |
| Abbott Laboratories | $760.90 | 21 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $489.29 | 26 | $0 (2024) |
| ABIOMED | $454.72 | 4 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $308.50 | 14 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $266.09 | 12 | $0 (2024) |
| Gilead Sciences, Inc. | $237.24 | 12 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $616.33 | 19 | Medtronic, Inc. ($368.23) |
| 2023 | $951.37 | 18 | Medtronic, Inc. ($453.99) |
| 2022 | $539.07 | 9 | Medtronic, Inc. ($349.99) |
| 2021 | $1,304 | 49 | Janssen Pharmaceuticals, Inc ($252.69) |
| 2020 | $662.87 | 20 | Abbott Laboratories ($270.37) |
| 2019 | $838.07 | 35 | Janssen Pharmaceuticals, Inc ($186.10) |
| 2018 | $2,523 | 37 | Philips Electronics North America Corporation ($1,354) |
| 2017 | $2,036 | 78 | Amgen Inc. ($661.20) |
All Payment Transactions
265 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Cardiology | ||||||
| 10/17/2024 | Medtronic, Inc. | LAUNCHER (Device) | Food and Beverage | In-kind items and services | $127.42 | General |
| Category: Catheters | ||||||
| 08/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Diabetes | ||||||
| 08/14/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Diabetes | ||||||
| 07/17/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Diabetes | ||||||
| 06/14/2024 | Medtronic, Inc. | ONYX FRONTIER (Device) | Food and Beverage | In-kind items and services | $94.39 | General |
| Category: Stents | ||||||
| 05/15/2024 | Medtronic, Inc. | ONYX FRONTIER (Device) | Food and Beverage | In-kind items and services | $90.98 | General |
| Category: Stents | ||||||
| 05/10/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Diabetes | ||||||
| 04/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Diabetes | ||||||
| 04/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $25.47 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/26/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.78 | General |
| Category: Cardiovascular | ||||||
| 03/23/2024 | ConvaTec Inc. | AQUACEL AG SURGICAL (Device) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 03/12/2024 | ATRICURE, INC. | SYNERGY ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/11/2024 | Medtronic, Inc. | ONYX FRONTIER (Device) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Stents | ||||||
| 02/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/30/2024 | Chiesi USA, Inc. | CLEVIPREX (Drug), KENGREAL | Food and Beverage | Cash or cash equivalent | $20.42 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/09/2024 | Medtronic, Inc. | ONYX FRONTIER (Device) | Food and Beverage | In-kind items and services | $38.28 | General |
| Category: Stents | ||||||
| 01/06/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Diabetes | ||||||
| 12/01/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Diabetes | ||||||
| 11/28/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Diabetes | ||||||
| 11/10/2023 | Medtronic, Inc. | EUPHORA (Device) | Food and Beverage | In-kind items and services | $93.19 | General |
| Category: Catheters | ||||||
| 10/31/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/27/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Diabetes | ||||||
| 10/26/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,184 | 1,588 | $284,751 | $107,318 |
| 2022 | 15 | 843 | 1,062 | $168,652 | $73,736 |
| 2021 | 17 | 797 | 1,105 | $248,196 | $99,493 |
| 2020 | 25 | 1,074 | 1,458 | $328,205 | $119,298 |
Total Patients
3,898
Total Services
5,213
Medicare Billing
$399,845
Procedure Codes
73
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 377 | 636 | $111,300 | $56,159 | 50.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 86 | 86 | $23,220 | $8,938 | 38.5% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 19 | 21 | $32,340 | $8,899 | 27.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 128 | 142 | $17,750 | $8,761 | 49.4% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 29 | 30 | $24,750 | $5,385 | 21.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 29 | 30 | $9,690 | $3,860 | 39.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 213 | 300 | $21,600 | $2,756 | 12.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 28 | 44 | $5,060 | $2,669 | 52.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 16 | 28 | $4,480 | $2,565 | 57.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 16 | $3,920 | $2,040 | 52.0% |
| 93226 | Electrocardiogram (ecg) 2-day continuous with report | Office | 2023 | 46 | 46 | $6,900 | $1,206 | 17.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $2,899 | $1,203 | 41.5% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Office | 2023 | 64 | 66 | $3,960 | $925.98 | 23.4% |
| 93225 | Electrocardiogram (ecg) 2-day continuous | Office | 2023 | 58 | 59 | $5,605 | $775.47 | 13.8% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 12 | 12 | $4,020 | $603.24 | 15.0% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 51 | 59 | $7,257 | $572.89 | 7.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 276 | 404 | $66,644 | $36,290 | 54.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 58 | 58 | $14,790 | $7,204 | 48.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 96 | 107 | $13,567 | $6,569 | 48.4% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 20 | 20 | $16,500 | $4,050 | 24.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 24 | 28 | $6,188 | $3,985 | 64.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 36 | 59 | $6,785 | $3,322 | 49.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 26 | 39 | $6,240 | $3,066 | 49.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 18 | 18 | $5,814 | $2,636 | 45.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 20 | 20 | $4,460 | $2,094 | 47.0% |
About Dr. Geetha Mohan, MD
Dr. Geetha Mohan, MD is a Interventional Cardiology healthcare provider based in Lorain, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316927668.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Geetha Mohan, MD has received a total of $9,471 in payments from pharmaceutical and medical device companies, with $616.33 received in 2024. These payments were reported across 265 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($7,718).
As a Medicare-enrolled provider, Mohan has provided services to 3,898 Medicare beneficiaries, totaling 5,213 services with total Medicare billing of $399,845. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Other Specialties Cardiovascular Disease
- Location Lorain, OH
- Active Since 01/20/2006
- Last Updated 01/07/2021
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1316927668
Products in Payments
- iFR (Device) $1,354
- XARELTO (Drug) $1,105
- ONYX FRONTIER (Device) $652.98
- Repatha (Biological) $651.00
- Impella (Device) $454.72
- ENTRESTO (Drug) $377.09
- CoreValve Evolut (Device) $260.38
- ELIQUIS (Drug) $244.52
- CardioMEMS HF System (Device) $232.61
- Corlanor (Drug) $183.46
- FARXIGA (Drug) $175.10
- Xience V coronary stent system (Device) $156.89
- NORTHERA (Drug) $139.33
- LifeVest (Device) $136.44
- Xience Sierra Coronary Stent (Device) $136.39
- BRILINTA (Drug) $133.40
- LAUNCHER (Device) $127.42
- KENGREAL (Drug) $125.00
- LUCEMYRA (Drug) $125.00
- NEXLIZET (Drug) $125.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.